HEADER TRANSFERASE 08-OCT-09 3K5V TITLE STRUCTURE OF ABL KINASE IN COMPLEX WITH IMATINIB AND GNF-2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE ABL1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN (UNP RESIDUES 229 TO 515); COMPND 5 SYNONYM: ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1, PROTO- COMPND 6 ONCOGENE C-ABL, P150; COMPND 7 EC: 2.7.10.2; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: ABL, ABL1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS KINASE, ATP-BINDING, NUCLEOTIDE-BINDING, ONCOGENE, SH2 DOMAIN, KEYWDS 2 TRANSFERASE, TYROSINE-PROTEIN KINASE EXPDTA X-RAY DIFFRACTION AUTHOR S.W.COWAN-JACOB,G.FENDRICH,G.RUMMEL,A.STRAUSS REVDAT 5 01-NOV-17 3K5V 1 REMARK REVDAT 4 06-APR-11 3K5V 1 JRNL REVDAT 3 01-DEC-10 3K5V 1 DBREF SEQADV SOURCE REVDAT 2 26-JAN-10 3K5V 1 JRNL REVDAT 1 19-JAN-10 3K5V 0 JRNL AUTH J.ZHANG,F.J.ADRIAN,W.JAHNKE,S.W.COWAN-JACOB,A.G.LI, JRNL AUTH 2 R.E.IACOB,T.SIM,J.POWERS,C.DIERKS,F.SUN,G.R.GUO,Q.DING, JRNL AUTH 3 B.OKRAM,Y.CHOI,A.WOJCIECHOWSKI,X.DENG,G.LIU,G.FENDRICH, JRNL AUTH 4 A.STRAUSS,N.VAJPAI,S.GRZESIEK,T.TUNTLAND,Y.LIU,B.BURSULAYA, JRNL AUTH 5 M.AZAM,P.W.MANLEY,J.R.ENGEN,G.Q.DALEY,M.WARMUTH,N.S.GRAY JRNL TITL TARGETING BCR-ABL BY COMBINING ALLOSTERIC WITH JRNL TITL 2 ATP-BINDING-SITE INHIBITORS. JRNL REF NATURE V. 463 501 2010 JRNL REFN ISSN 0028-0836 JRNL PMID 20072125 JRNL DOI 10.1038/NATURE08675 REMARK 2 REMARK 2 RESOLUTION. 1.74 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0063 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.74 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.95 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 95.4 REMARK 3 NUMBER OF REFLECTIONS : 61682 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.201 REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.231 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3247 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.74 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.79 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4011 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 83.82 REMARK 3 BIN R VALUE (WORKING SET) : 0.2640 REMARK 3 BIN FREE R VALUE SET COUNT : 211 REMARK 3 BIN FREE R VALUE : 0.2890 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4620 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 129 REMARK 3 SOLVENT ATOMS : 429 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 31.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.31 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.69000 REMARK 3 B22 (A**2) : 0.30000 REMARK 3 B33 (A**2) : 0.48000 REMARK 3 B12 (A**2) : 0.03000 REMARK 3 B13 (A**2) : 0.49000 REMARK 3 B23 (A**2) : -0.43000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.127 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.121 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.077 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.335 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.953 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.936 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4895 ; 0.009 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6631 ; 1.176 ; 1.990 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 571 ; 5.460 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 223 ;36.015 ;24.439 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 847 ;12.949 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 22 ;14.107 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 687 ; 0.086 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3726 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2849 ; 1.043 ; 2.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4603 ; 1.910 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2046 ; 2.165 ; 4.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2026 ; 3.273 ; 5.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3K5V COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-OCT-09. REMARK 100 THE DEPOSITION ID IS D_1000055584. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-FEB-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0016 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 64929 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.740 REMARK 200 RESOLUTION RANGE LOW (A) : 62.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.3 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : 0.05200 REMARK 200 R SYM (I) : 0.04500 REMARK 200 FOR THE DATA SET : 16.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.74 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.80 REMARK 200 COMPLETENESS FOR SHELL (%) : 86.2 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : 0.45000 REMARK 200 R SYM FOR SHELL (I) : 0.38200 REMARK 200 FOR SHELL : 3.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: REFMAC 5.5.0063 REMARK 200 STARTING MODEL: PDB ENTRY 1OPJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.54 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M MES PH 5.6, 0.2 M MGCL2, 18 % REMARK 280 PEG 4000, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 242 REMARK 465 THR A 296 REMARK 465 GLY A 530 REMARK 465 LYS A 531 REMARK 465 ARG A 532 REMARK 465 GLY A 533 REMARK 465 THR A 534 REMARK 465 GLY B 242 REMARK 465 ALA B 243 REMARK 465 GLU B 294 REMARK 465 ASP B 295 REMARK 465 THR B 296 REMARK 465 GLY B 530 REMARK 465 LYS B 531 REMARK 465 ARG B 532 REMARK 465 GLY B 533 REMARK 465 THR B 534 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER B 248 OD1 ASN B 250 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 440 CB - CG - OD1 ANGL. DEV. = 5.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 264 -147.10 -106.52 REMARK 500 LYS A 281 -70.03 -40.22 REMARK 500 ARG A 381 -18.23 87.70 REMARK 500 ASP A 382 53.27 -149.94 REMARK 500 LYS B 264 -129.39 -98.35 REMARK 500 ARG B 381 -16.51 86.12 REMARK 500 ASP B 382 50.78 -149.82 REMARK 500 SER B 519 143.02 -173.30 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE STJ A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE STI A 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE STJ B 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE STI B 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 5 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1OPJ RELATED DB: PDB DBREF 3K5V A 248 534 UNP P00520 ABL1_MOUSE 229 515 DBREF 3K5V B 248 534 UNP P00520 ABL1_MOUSE 229 515 SEQADV 3K5V GLY A 242 UNP P00520 EXPRESSION TAG SEQADV 3K5V ALA A 243 UNP P00520 EXPRESSION TAG SEQADV 3K5V MET A 244 UNP P00520 EXPRESSION TAG SEQADV 3K5V ASP A 245 UNP P00520 EXPRESSION TAG SEQADV 3K5V PRO A 246 UNP P00520 EXPRESSION TAG SEQADV 3K5V SER A 247 UNP P00520 EXPRESSION TAG SEQADV 3K5V GLY B 242 UNP P00520 EXPRESSION TAG SEQADV 3K5V ALA B 243 UNP P00520 EXPRESSION TAG SEQADV 3K5V MET B 244 UNP P00520 EXPRESSION TAG SEQADV 3K5V ASP B 245 UNP P00520 EXPRESSION TAG SEQADV 3K5V PRO B 246 UNP P00520 EXPRESSION TAG SEQADV 3K5V SER B 247 UNP P00520 EXPRESSION TAG SEQRES 1 A 293 GLY ALA MET ASP PRO SER SER PRO ASN TYR ASP LYS TRP SEQRES 2 A 293 GLU MET GLU ARG THR ASP ILE THR MET LYS HIS LYS LEU SEQRES 3 A 293 GLY GLY GLY GLN TYR GLY GLU VAL TYR GLU GLY VAL TRP SEQRES 4 A 293 LYS LYS TYR SER LEU THR VAL ALA VAL LYS THR LEU LYS SEQRES 5 A 293 GLU ASP THR MET GLU VAL GLU GLU PHE LEU LYS GLU ALA SEQRES 6 A 293 ALA VAL MET LYS GLU ILE LYS HIS PRO ASN LEU VAL GLN SEQRES 7 A 293 LEU LEU GLY VAL CYS THR ARG GLU PRO PRO PHE TYR ILE SEQRES 8 A 293 ILE THR GLU PHE MET THR TYR GLY ASN LEU LEU ASP TYR SEQRES 9 A 293 LEU ARG GLU CYS ASN ARG GLN GLU VAL SER ALA VAL VAL SEQRES 10 A 293 LEU LEU TYR MET ALA THR GLN ILE SER SER ALA MET GLU SEQRES 11 A 293 TYR LEU GLU LYS LYS ASN PHE ILE HIS ARG ASP LEU ALA SEQRES 12 A 293 ALA ARG ASN CYS LEU VAL GLY GLU ASN HIS LEU VAL LYS SEQRES 13 A 293 VAL ALA ASP PHE GLY LEU SER ARG LEU MET THR GLY ASP SEQRES 14 A 293 THR TYR THR ALA HIS ALA GLY ALA LYS PHE PRO ILE LYS SEQRES 15 A 293 TRP THR ALA PRO GLU SER LEU ALA TYR ASN LYS PHE SER SEQRES 16 A 293 ILE LYS SER ASP VAL TRP ALA PHE GLY VAL LEU LEU TRP SEQRES 17 A 293 GLU ILE ALA THR TYR GLY MET SER PRO TYR PRO GLY ILE SEQRES 18 A 293 ASP LEU SER GLN VAL TYR GLU LEU LEU GLU LYS ASP TYR SEQRES 19 A 293 ARG MET GLU ARG PRO GLU GLY CYS PRO GLU LYS VAL TYR SEQRES 20 A 293 GLU LEU MET ARG ALA CYS TRP GLN TRP ASN PRO SER ASP SEQRES 21 A 293 ARG PRO SER PHE ALA GLU ILE HIS GLN ALA PHE GLU THR SEQRES 22 A 293 MET PHE GLN GLU SER SER ILE SER ASP GLU VAL GLU LYS SEQRES 23 A 293 GLU LEU GLY LYS ARG GLY THR SEQRES 1 B 293 GLY ALA MET ASP PRO SER SER PRO ASN TYR ASP LYS TRP SEQRES 2 B 293 GLU MET GLU ARG THR ASP ILE THR MET LYS HIS LYS LEU SEQRES 3 B 293 GLY GLY GLY GLN TYR GLY GLU VAL TYR GLU GLY VAL TRP SEQRES 4 B 293 LYS LYS TYR SER LEU THR VAL ALA VAL LYS THR LEU LYS SEQRES 5 B 293 GLU ASP THR MET GLU VAL GLU GLU PHE LEU LYS GLU ALA SEQRES 6 B 293 ALA VAL MET LYS GLU ILE LYS HIS PRO ASN LEU VAL GLN SEQRES 7 B 293 LEU LEU GLY VAL CYS THR ARG GLU PRO PRO PHE TYR ILE SEQRES 8 B 293 ILE THR GLU PHE MET THR TYR GLY ASN LEU LEU ASP TYR SEQRES 9 B 293 LEU ARG GLU CYS ASN ARG GLN GLU VAL SER ALA VAL VAL SEQRES 10 B 293 LEU LEU TYR MET ALA THR GLN ILE SER SER ALA MET GLU SEQRES 11 B 293 TYR LEU GLU LYS LYS ASN PHE ILE HIS ARG ASP LEU ALA SEQRES 12 B 293 ALA ARG ASN CYS LEU VAL GLY GLU ASN HIS LEU VAL LYS SEQRES 13 B 293 VAL ALA ASP PHE GLY LEU SER ARG LEU MET THR GLY ASP SEQRES 14 B 293 THR TYR THR ALA HIS ALA GLY ALA LYS PHE PRO ILE LYS SEQRES 15 B 293 TRP THR ALA PRO GLU SER LEU ALA TYR ASN LYS PHE SER SEQRES 16 B 293 ILE LYS SER ASP VAL TRP ALA PHE GLY VAL LEU LEU TRP SEQRES 17 B 293 GLU ILE ALA THR TYR GLY MET SER PRO TYR PRO GLY ILE SEQRES 18 B 293 ASP LEU SER GLN VAL TYR GLU LEU LEU GLU LYS ASP TYR SEQRES 19 B 293 ARG MET GLU ARG PRO GLU GLY CYS PRO GLU LYS VAL TYR SEQRES 20 B 293 GLU LEU MET ARG ALA CYS TRP GLN TRP ASN PRO SER ASP SEQRES 21 B 293 ARG PRO SER PHE ALA GLU ILE HIS GLN ALA PHE GLU THR SEQRES 22 B 293 MET PHE GLN GLU SER SER ILE SER ASP GLU VAL GLU LYS SEQRES 23 B 293 GLU LEU GLY LYS ARG GLY THR HET STJ A 1 27 HET STI A 2 37 HET CL A 5 1 HET STJ B 1 27 HET STI B 2 37 HETNAM STJ 3-(6-{[4-(TRIFLUOROMETHOXY)PHENYL]AMINO}PYRIMIDIN-4- HETNAM 2 STJ YL)BENZAMIDE HETNAM STI 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4- HETNAM 2 STI PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE HETNAM CL CHLORIDE ION HETSYN STI STI-571;IMATINIB FORMUL 3 STJ 2(C18 H13 F3 N4 O2) FORMUL 4 STI 2(C29 H31 N7 O) FORMUL 5 CL CL 1- FORMUL 8 HOH *429(H2 O) HELIX 1 1 GLU A 257 THR A 259 5 3 HELIX 2 2 GLY A 268 GLN A 271 5 4 HELIX 3 3 LYS A 282 SER A 284 5 3 HELIX 4 4 GLU A 298 GLU A 311 1 14 HELIX 5 5 LEU A 342 CYS A 349 1 8 HELIX 6 6 SER A 355 LYS A 376 1 22 HELIX 7 7 ALA A 384 ARG A 386 5 3 HELIX 8 8 GLU A 392 HIS A 394 5 3 HELIX 9 9 PRO A 421 THR A 425 5 5 HELIX 10 10 ALA A 426 ASN A 433 1 8 HELIX 11 11 SER A 436 THR A 453 1 18 HELIX 12 12 ASP A 463 SER A 465 5 3 HELIX 13 13 GLN A 466 LYS A 473 1 8 HELIX 14 14 PRO A 484 TRP A 495 1 12 HELIX 15 15 ASN A 498 ARG A 502 5 5 HELIX 16 16 SER A 504 PHE A 516 1 13 HELIX 17 17 SER A 520 LEU A 529 1 10 HELIX 18 18 GLU B 257 THR B 259 5 3 HELIX 19 19 GLY B 268 GLN B 271 5 4 HELIX 20 20 LYS B 282 SER B 284 5 3 HELIX 21 21 GLU B 298 GLU B 311 1 14 HELIX 22 22 ASN B 341 CYS B 349 1 9 HELIX 23 23 SER B 355 LYS B 376 1 22 HELIX 24 24 ALA B 384 ARG B 386 5 3 HELIX 25 25 GLU B 392 HIS B 394 5 3 HELIX 26 26 PRO B 421 THR B 425 5 5 HELIX 27 27 ALA B 426 ASN B 433 1 8 HELIX 28 28 SER B 436 THR B 453 1 18 HELIX 29 29 ASP B 463 SER B 465 5 3 HELIX 30 30 GLN B 466 LYS B 473 1 8 HELIX 31 31 PRO B 484 TRP B 495 1 12 HELIX 32 32 ASN B 498 ARG B 502 5 5 HELIX 33 33 SER B 504 MET B 515 1 12 HELIX 34 34 SER B 520 LEU B 529 1 10 SHEET 1 A 5 ILE A 261 LYS A 266 0 SHEET 2 A 5 VAL A 275 TRP A 280 -1 O GLU A 277 N LYS A 264 SHEET 3 A 5 LEU A 285 THR A 291 -1 O LEU A 285 N TRP A 280 SHEET 4 A 5 TYR A 331 GLU A 335 -1 O ILE A 332 N LYS A 290 SHEET 5 A 5 LEU A 320 CYS A 324 -1 N LEU A 321 O ILE A 333 SHEET 1 B 3 GLY A 340 ASN A 341 0 SHEET 2 B 3 CYS A 388 VAL A 390 -1 O VAL A 390 N GLY A 340 SHEET 3 B 3 VAL A 396 VAL A 398 -1 O LYS A 397 N LEU A 389 SHEET 1 C 2 THR A 413 HIS A 415 0 SHEET 2 C 2 ALA A 418 PHE A 420 -1 O PHE A 420 N THR A 413 SHEET 1 D 5 ILE B 261 LYS B 266 0 SHEET 2 D 5 VAL B 275 TRP B 280 -1 O GLU B 277 N HIS B 265 SHEET 3 D 5 LEU B 285 THR B 291 -1 O VAL B 289 N TYR B 276 SHEET 4 D 5 TYR B 331 GLU B 335 -1 O ILE B 332 N LYS B 290 SHEET 5 D 5 LEU B 320 CYS B 324 -1 N LEU B 321 O ILE B 333 SHEET 1 E 2 CYS B 388 VAL B 390 0 SHEET 2 E 2 VAL B 396 VAL B 398 -1 O LYS B 397 N LEU B 389 SHEET 1 F 2 THR B 413 HIS B 415 0 SHEET 2 F 2 ALA B 418 PHE B 420 -1 O ALA B 418 N HIS B 415 CISPEP 1 PRO A 328 PRO A 329 0 -0.39 CISPEP 2 PRO B 328 PRO B 329 0 -4.99 SITE 1 AC1 16 ALA A 356 LEU A 359 LEU A 360 ALA A 363 SITE 2 AC1 16 LEU A 448 ILE A 451 ALA A 452 TYR A 454 SITE 3 AC1 16 GLU A 481 PRO A 484 PHE A 512 ILE A 521 SITE 4 AC1 16 LEU A 529 HOH A 536 HOH A 561 HOH A 619 SITE 1 AC2 16 HOH A 22 ALA A 288 LYS A 290 GLU A 305 SITE 2 AC2 16 MET A 309 ILE A 312 VAL A 318 ILE A 332 SITE 3 AC2 16 THR A 334 PHE A 336 MET A 337 ILE A 379 SITE 4 AC2 16 HIS A 380 ALA A 399 ASP A 400 PHE A 401 SITE 1 AC3 10 LEU B 359 LEU B 360 ALA B 363 LEU B 448 SITE 2 AC3 10 ILE B 451 ALA B 452 GLU B 481 VAL B 487 SITE 3 AC3 10 PHE B 512 HOH B 619 SITE 1 AC4 17 HOH B 47 LEU B 267 VAL B 275 ALA B 288 SITE 2 AC4 17 LYS B 290 GLU B 305 MET B 309 ILE B 312 SITE 3 AC4 17 VAL B 318 ILE B 332 THR B 334 MET B 337 SITE 4 AC4 17 ILE B 379 HIS B 380 ALA B 399 ASP B 400 SITE 5 AC4 17 PHE B 401 SITE 1 AC5 3 ILE A 379 HOH A 660 HOH A 679 CRYST1 42.070 65.268 66.259 72.82 80.25 84.86 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023770 -0.002139 -0.003625 0.00000 SCALE2 0.000000 0.015383 -0.004581 0.00000 SCALE3 0.000000 0.000000 0.015978 0.00000 MASTER 334 0 5 34 19 0 17 6 0 0 0 46 END